Acyclovir for treating varicella in otherwise healthy children and adolescents

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 1, 2005, Pages

  Klassen, Terry P ^a   Hartling, Lisa ^b  

^a MANITOBA INSTITUTE OF CHILD HEALTH   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT;

ADOLESCENT; CHICKENPOX; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ACYCLOVIR; ADOLESCENT; ANTIVIRAL AGENTS; CHICKENPOX; CHILD; CHILD, PRESCHOOL; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 33644873649     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002980.pub3     Document Type: Review

References (44)

1. Balfour HH Jr, Kelly JM, Suarez CS, Heussner RC, Englund JA, Crane DD, et al. Acyclovir treatment of varicella in otherwise healthy children. Journal of Pediatrics 1990;116(4):633-9.
2. McGuirt PV, Clemmer A. Treatment of Chickenpox in Children with Acyclovir Suspension in a Double-Blind Placebo-Controlled Clinical Trial. Final Medical Report (Protocol ZOVIRAX 176). Available from: Burroughs Wellcome Co., Research Triangle Park, N.C. U.S.A 1988.
3. Balfour HH Jr, Rotbart HA, Feldman S, Dunkle LM, Feder HM Jr, Prober CG, et al. Acyclovir treatment of varicella in otherwise healthy adolescents. Journal of Pediatrics 1992;120:627-33.
4. McGuirt PV, Boone G, Harris J. Treatment of Chickenpox in Adolescents with AOVIRAZ Tablets in a Multicenter, Double-Blind, Placebo-Controlled Trial. Final Medical Report (Protocol ZOVIRAX 184). Available from: Burroughs Wellcome Co., Research Triangle Park, N.C. U.S.A 1990.
5. Dunkle LM, Arvin AM, Whitley RJ, Rotbart HA, Feder HM Jr, Feldman S, et al. A controlled trial of acyclovir for chickenpox in normal children. New England Journal of Medicine 1991;325:1539-44.
6. McGuirt PV, Boone G, Harris J. Treatment of Chickenpox in Children with ZOVIRAX Suspension in a Multicenter, Double-Blind, Placebo-Controlled Trial. Final Medical Report (Protocol ZOVIRAX 183). Available from: Burroughs Wellcome Co., Research Triangle, N.C. U.S.A 1990.
7. Balfour HH Jr, Edelman CK, Anderson RS, Reed NV, Slivken RM, Marmor LH, et al. Controlled trial of acyclovir for chickenpox evaluating time of initiation and duration of therapy and viral resistance. Pediatric Infectious Disease Journal 2001;20:919-26.
8. Feder HM. Treatment of adult chickenpox with oral acyclovir. Archives of Internal Medicine 1990;150:2061-5.
9. Huang Y-C, Lin T-Y, Chiu C-H. Acyclovir prophylaxis of varicella after household exposure. Pediatric Infectious Disease Journal 1995;14:152-4.
10. Lin T-Y, Huang Y-C, Ning H-C, Hsueh C. Oral acyclovir prophylaxis of varicella after intimate contact. Pediatric Infectious Disease Journal 1997;16:1162-5.
11. Suga S, Yoshikawa T, Ozaki T, Asano Y. Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella. Archives of Disease in Childhood 1993;69:639-43.
12. Arvin AM. Oral therapy with acyclovir in infants and children. Pediatric Infectious Disease Journal 1987;6:56-8.
13. Avery ME. Varicella-zoster. In: Avery ME, First LR editor(s). Pediatric Medicine. 2nd Edition. Baltimore: Williams and Wilkins, 1989:1180-1.
14. Balfour HH. No reason not to treat. BMJ 1995;310:109-10.
15. Brunell PA. Varicella-zoster infections. In: Feign RD, Cherry JD editor(s). Textbook of pediatric infectious diseases. 2nd Edition. Philadelphia: WB Saunders, 1987:1602-7.
16. Brunell PA. Chickenpox-examining our options. New England Journal of Medicine 1991;325(22):1577-99.
17. Centers for Disease Control and Prevention. Infectious diseases information: Varicella-Zoster Virus. CDC: National Center for Infectious Diseases 2001 (www.cdc.gov/ncidod/diseases/list_varicl.htm).
18. Cole NL, Balfour HH Jr. Varicella-zoster virus does not become more resistant to acyclovir during therapy. Journal of Infectious Diseases 1986;153:605-8.
19. Conway SP. Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella (commentary). Archives of Disease in Childhood 1993;69:642-3.
20. Canadian Paediatric Society (CPS). School and daycare exclusion policies for chickenpox: A rational approach. Infectious Diseases Immunization Committee, Canadian Paediatric Society. Paediatrics and Child Health 1999;4(4):287-8.
21. Croze SM, Stoukides CA. Oral acyclovir in immunocompetent patients with varicella. Annals of Pharmacotherapy 1994;28:208-9.
22. Drwal-Klein LA, O'Donovan CA. Varicella in Pediatric Patients. Annals of Pharmocotherapy 1993;27(July/August):938-49.
23. Englund JA, Zimmerman ME, Swierkosz DM, Goodman JL, Schll DR, Balfour HH Jr. Acyclovir resistant herpex simplex virus: results from a tertiary care center. Annals of Internal Medicine 1990;112:416-22.
24. Feldhoff CM, Balfour HH Jr, Simmons RL, Najarian JS, Mauer SM. Varicella in children with renal transplants. Journal of Pediatrics 1981;98:25-31.
25. Feldman SF, Hughes WT, Daniel CB. Varicella in children with cancer: seventy-seven cases. Pediatrics 1975;56:388-97.
26. Gershon AA. Varicella in mother and infant: problems old and new. In: Krugman S, Gershon AA editor(s). Infections of the fetus and newborn infant. New York: Alan R. Liss, Inc, 1975:75-95.
27. Ghirga G, Ghirga P, Pizzabiocca A, Maccarini I, Presti A. Treatment of varicella with low doses of acyclovir for two days (letter; comment). Journal of Pediatrics 1992;120(4 Part 1):664-5.
28. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
29. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
30. Laskin OL. Acyclovir: pharmacology and clinical experience. Archives of Internal Medicine 1984;144:1241-6.
31. Lefebvre C, Manheimer E, Glanville J. Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: sensitivity- and precision- maximizing version (2008 revision); Ovid format. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chapter 6: Searching for studies. Chichester, UK: John Wiley & Sons, Ltd, 2008.
32. McKendrick MW. Acyclovir for childhood chickenpox. Cost is unjustified. BMJ 1995;310:108-9.
33. Meyers JD. Congenital varicella in term infants; risk reconsidered. Journal of Infectious Diseases 1974;129:215-7.
34. Moore DA, Hopkins RS. Assessment of a school exclusion policy during a chickenpox outbreak. American Journal of Epidemiology 1991;133:1161-7.
35. Mouzard A. Traitement par antiviral de la varicelle du nourrisson et de l'enfant: les arguments contre. Medecine et maladies infectieuses 1998;28:832-6.
36. Preblud SR. Age-specific risks of varicella complications. Pediatrics 1981;68(1):14-7.
37. Preblud SR, Orenstein WA, Bart KJ. Varicella: clinical manifestations, epidemiology and health impact in children. Pediatric Infectious Diseases Journal 1984;3(6):505-9.
38. Preblud SR. Varicella: Complications and costs. Pediatrics 1986;78(Suppl):728-35.
39. Ross AH. Modification of chickenpox in family contacts by administration of gamma globulin. New England Journal of Medicine 1962;267:369-76.
40. Rotbart HA, Levin MJ, Hayward AR. Immune responses to varicella zoster virus infections in healthy children. Journal of Infectious Diseases 1993;167:195-9.
41. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273:408-12.
42. Klassen TP, Belseck EM, Wiebe N, Hartling L. Acyclovir for treating varicella in otherwise healthy children and adolescents: a systematic review of randomised controlled trials. BioMed Central Pediatrics 2002;2(1):9.
43. Klassen TP, Belseck EM, Wiebe N, Hartling L. Acyclovir for treating varicella in otherwise healthy children and adolescents. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD002980.pub3]
44. Klassen TP, Hartling L, Wiebe N, Belseck EM. Acyclovir for treating varicella in otherwise healthy children and adolescents. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD002980.pub3]